ALTRAZEAL LIFE SCIENCES INC — Department of Defense SBIR Phase II: PROPOSAL TITLED INNOVATIVE AND ADAPTIVE DRUG DELIVERY SYSTEM FOR ENHANCED NEUROPROTECTION
ALTRAZEAL LIFE SCIENCES INC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,300,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
This Phase II award supports development of an adaptive drug delivery system to protect and repair brain tissue after penetrating injuries or skull fractures in low-resource settings. The goal is to improve outcomes for traumatic brain injuries in challenging military environments.
- Amount
- $1,300,000
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- TX
- Period
- 2025-09-05 → 2028-01-04
Technology domains
Description
SBIR PHASE II PROPOSAL TITLED INNOVATIVE AND ADAPTIVE DRUG DELIVERY SYSTEM FOR ENHANCED NEUROPROTECTION AND REPAIR IN TRAUMATIC BRAIN INJURIES FROM PENETRATING TRAUMA OR OPEN SKULL FRACTURES IN LOW RESOURCE ENVIRONMENTS